Data for Insights into the pathogenesis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through metabolomic profiling of cerebrospinal fluid (Study ST000912)
(Analysis AN001482)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 | F4 | F5 | F6 |
---|---|---|---|---|---|---|
1_Ceramide (d18:1/17:0) iSTD | 1.0330 | 1.0067 | 1.0008 | 0.9820 | 0.9555 | 1.0006 |
1_CUDA iSTD | 0.9982 | 0.9957 | 1.0058 | 0.9958 | 0.9983 | 0.9997 |
1_FA (16:0)-d3 iSTD | 1.0199 | 1.2509 | 0.9780 | 0.9946 | 0.9086 | 0.7818 |
1_LPC (17:0) iSTD | 1.0166 | 1.0013 | 1.0004 | 0.9982 | 0.9816 | 0.9811 |
1_LPE (17:1) iSTD | 1.0255 | 0.9999 | 1.0077 | 0.9904 | 0.9702 | 0.9588 |
1_MAG (17:0/0:0/0:0) iSTD | 1.0252 | 0.9958 | 0.9973 | 0.9926 | 0.9839 | 0.9819 |
1_PC (12:0/13:0) iSTD | 1.0121 | 0.9864 | 1.0054 | 0.9778 | 1.0002 | 1.0015 |
1_PE (17:0/17:0) iSTD | 1.0009 | 1.0085 | 0.9988 | 0.9879 | 1.0005 | 1.0102 |
1_PG (17:0/17:0) iSTD | 1.0132 | 0.9996 | 0.9959 | 0.9745 | 1.0168 | 0.9878 |
1_SM (d18:1/17:0) iSTD | 1.0130 | 0.9982 | 1.0074 | 0.9894 | 0.9867 | 0.9734 |
Ceramide (d33:1) | 1.0439 | 0.9641 | 1.0075 | 0.9041 | 1.0009 | 1.0669 |
FA (10:0) (capric acid) | 0.9815 | 1.3709 | 0.8610 | 0.9649 | 1.1225 | 0.8379 |
FA (12:0) (lauric acid) | 1.0410 | 1.2222 | 0.8903 | 0.8648 | 1.1338 | 0.9416 |
FA (14:0) (myristic acid) | 1.0009 | 1.2287 | 0.9397 | 0.9829 | 0.9841 | 0.9279 |
FA (15:0) (pentadecylic acid) | 1.0265 | 1.2503 | 0.9774 | 0.9942 | 0.8558 | 0.8778 |
FA (16:0) (palmitic acid) | 0.9162 | 1.1196 | 1.0214 | 1.0827 | 0.9551 | 0.9061 |
FA (17:0) (margaric acid) | 1.0108 | 1.0644 | 0.9920 | 1.0234 | 0.9410 | 0.9623 |
FA (18:0) (stearic acid) | 1.0159 | 0.9973 | 0.9757 | 1.0284 | 0.9813 | 1.0466 |
FA (18:1) (oleic acid) | 1.0047 | 1.0736 | 0.9326 | 0.9432 | 1.0572 | 1.1531 |
FA (18:2) (linoleic acid) | 0.8610 | 1.0301 | 0.9743 | 0.8633 | 1.2310 | 1.3245 |
FA (20:0) (arachidic acid) | 1.0176 | 1.0207 | 0.9602 | 1.0799 | 0.9625 | 1.0075 |
FA (20:1) (eicosenoic acid) | 1.0614 | 1.2273 | 0.9672 | 0.9247 | 0.8611 | 0.9731 |
FA (22:0) (behenic acid) | 0.9877 | 1.0973 | 1.0000 | 1.0605 | 0.9216 | 0.9134 |
FA (22:1) (erucic acid) | 1.0389 | 0.9248 | 1.0667 | 0.9580 | 0.9320 | 0.9215 |
FA (24:0) (lignoceric acid) | 1.0370 | 1.2122 | 1.0249 | 0.8469 | 0.8513 | 0.9935 |
FA (26:0) (cerotic acid) | 0.9810 | 1.1168 | 1.0312 | 0.9805 | 0.9256 | 0.9071 |
FA (28:0) (montanic acid) | 0.9830 | 1.0661 | 1.0148 | 0.9997 | 0.9469 | 0.9850 |
PC (32:0) | 0.9769 | 0.8692 | 0.9389 | 0.8921 | 1.5118 | 0.7129 |
PC (34:1) | 0.9938 | 0.8501 | 0.9490 | 0.9794 | 1.3745 | 0.7640 |
PC (34:2) | 1.0317 | 0.8038 | 0.9641 | 0.8699 | 1.4263 | 0.7529 |
PC (36:1) | 0.9594 | 0.8644 | 0.9541 | 0.8955 | 1.4450 | 0.8497 |
PC (36:2) | 1.0161 | 0.7994 | 1.0210 | 0.8330 | 1.3265 | 0.8403 |
PC (38:4) A | 0.9472 | 0.8476 | 0.9556 | 0.9211 | 1.5293 | 0.6822 |
PE (p-40:6) or PE (o-40:7) | 1.0392 | 0.8871 | 0.9438 | 1.0557 | 1.2488 | 0.6812 |
SM (d34:1) | 0.9297 | 0.8236 | 0.9415 | 0.8798 | 1.6006 | 0.7816 |
SM (d36:1) | 1.0018 | 0.9745 | 0.9611 | 0.9181 | 1.2732 | 0.7940 |
Factors:
F1 | Diagnosis:MECFS | Sex:FEMALE |
F2 | Diagnosis:MECFS | Sex:MALE |
F3 | Diagnosis:MS | Sex:FEMALE |
F4 | Diagnosis:MS | Sex:MALE |
F5 | Diagnosis:ND | Sex:FEMALE |
F6 | Diagnosis:ND | Sex:MALE |